
The Future of Biotech? Meet the Game-Changer in Nasdaq: TNXP
Tonix Pharmaceuticals (Nasdaq: TNXP) is leading biotech innovation in infectious diseases and immunology. Their proprietary live attenuated vaccines and small molecules aim to address current health challenges and future pandemics. Tonix’s novel cell therapy approach targets severe COVID-19 and other global health